Senate Bill S2745

2009-2010 Legislative Session

Establishes a business franchise and personal income tax credit for the targeted human pharmacological project fee paid to the Food and Drug Administration

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Investigations And Government Operations Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

2009-S2745 - Details

Current Committee:
Senate Investigations And Government Operations
Law Section:
Tax Law
Laws Affected:
Add §31, amd §§210 & 606, Tax L

2009-S2745 - Summary

Establishes a business franchise and personal income tax credit for the targeted human pharmacological project fee paid to the Food and Drug Administration for the purposes of submitting a human drug application or supplement when the research and development were primarily done in this state.

2009-S2745 - Sponsor Memo

2009-S2745 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2745

                       2009-2010 Regular Sessions

                            I N  S E N A T E

                              March 2, 2009
                               ___________

Introduced  by  Sen.  GOLDEN -- read twice and ordered printed, and when
  printed to be committed to the Committee on Investigations and Govern-
  ment Operations

AN ACT to amend the tax law, in  relation  to  establishing  a  targeted
  human pharmacological project fee credit

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The tax law is amended by adding a new section 30  to  read
as follows:
  S  30.  TARGETED  HUMAN  PHARMACOLOGICAL PROJECT FEE CREDIT. (A) DEFI-
NITIONS.  AS USED IN THIS SECTION THE FOLLOWING  TERMS  SHALL  HAVE  THE
FOLLOWING MEANINGS:
  (1) "PRIMARILY" SHALL MEAN MORE THAN FIFTY PERCENT.
  (2)  "RESEARCH  AND  DEVELOPMENT  COSTS"  SHALL MEAN IN-HOUSE RESEARCH
EXPENSES WITHIN THE MEANING OF SECTION 41 (B) (2) OF THE INTERNAL REVEN-
UE CODE.
  (3) "PROJECT FEES" SHALL MEAN THE MONETARY AMOUNT ACTUALLY PAID TO THE
U.S.F.D.A. THAT CONSTITUTES THE FEE DUE UPON THE SUBMISSION OF  A  HUMAN
DRUG  APPLICATION OR SUPPLEMENT PURSUANT TO U.S.C. S 379 H (A) (1) FOR A
HUMAN DRUG, RESEARCH AND  DEVELOPMENT  COSTS  OF  WHICH  WERE  PRIMARILY
INCURRED IN NEW YORK STATE.
  (4)  "U.S.F.D.A."  SHALL MEAN THE UNITED STATES FOOD AND DRUG ADMINIS-
TRATION.
  (B) TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (1) A  TAXPAYER
WHO IS SUBJECT TO TAX UNDER ARTICLE NINE-A OR TWENTY-TWO OF THIS CHAPTER
SHALL BE ALLOWED A CREDIT AGAINST SUCH TAX. SUCH CREDIT SHALL BE ALLOWED
WITH RESPECT TO PROJECT FEES.
  (2)  THE  APPLICABLE  PERCENTAGE SHALL EQUAL THIRTY-SIX PERCENT OF THE
COST OF PROJECT FEES.
  (3) THE CREDIT ALLOWED UNDER THIS SECTION MAY ONLY  BE  CLAIMED  AFTER
ITS LICENSURE IS APPROVED BY THE U.S.F.D.A. AND THE TAXPAYER IS LICENSED

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD07650-01-9
              

co-Sponsors

2009-S2745A (ACTIVE) - Details

Current Committee:
Senate Investigations And Government Operations
Law Section:
Tax Law
Laws Affected:
Add §31, amd §§210 & 606, Tax L

2009-S2745A (ACTIVE) - Summary

Establishes a business franchise and personal income tax credit for the targeted human pharmacological project fee paid to the Food and Drug Administration for the purposes of submitting a human drug application or supplement when the research and development were primarily done in this state.

2009-S2745A (ACTIVE) - Sponsor Memo

2009-S2745A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 2745--A

                       2009-2010 Regular Sessions

                            I N  S E N A T E

                              March 2, 2009
                               ___________

Introduced  by  Sens.  GOLDEN, HANNON -- read twice and ordered printed,
  and when printed to be committed to the  Committee  on  Investigations
  and  Government  Operations  --  committee  discharged,  bill amended,
  ordered reprinted as amended and recommitted to said committee

AN ACT to amend the tax law, in  relation  to  establishing  a  targeted
  human pharmacological project fee credit

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The tax law is amended by adding a new section 31  to  read
as follows:
  S  31.  TARGETED  HUMAN  PHARMACOLOGICAL PROJECT FEE CREDIT. (A) DEFI-
NITIONS.  AS USED IN THIS SECTION THE FOLLOWING  TERMS  SHALL  HAVE  THE
FOLLOWING MEANINGS:
  (1) "PRIMARILY" SHALL MEAN MORE THAN FIFTY PERCENT.
  (2)  "RESEARCH  AND  DEVELOPMENT  COSTS"  SHALL MEAN IN-HOUSE RESEARCH
EXPENSES WITHIN THE MEANING OF SECTION 41 (B) (2) OF THE INTERNAL REVEN-
UE CODE.
  (3) "PROJECT FEES" SHALL MEAN THE MONETARY AMOUNT ACTUALLY PAID TO THE
U.S.F.D.A. THAT CONSTITUTES THE FEE DUE UPON THE SUBMISSION OF  A  HUMAN
DRUG  APPLICATION OR SUPPLEMENT PURSUANT TO U.S.C. S 379 H (A) (1) FOR A
HUMAN DRUG, RESEARCH AND  DEVELOPMENT  COSTS  OF  WHICH  WERE  PRIMARILY
INCURRED IN NEW YORK STATE.
  (4)  "U.S.F.D.A."  SHALL MEAN THE UNITED STATES FOOD AND DRUG ADMINIS-
TRATION.
  (B) TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (1) A  TAXPAYER
WHO IS SUBJECT TO TAX UNDER ARTICLE NINE-A OR TWENTY-TWO OF THIS CHAPTER
SHALL BE ALLOWED A CREDIT AGAINST SUCH TAX. SUCH CREDIT SHALL BE ALLOWED
WITH RESPECT TO PROJECT FEES.
  (2)  THE  APPLICABLE  PERCENTAGE SHALL EQUAL THIRTY-SIX PERCENT OF THE
COST OF PROJECT FEES.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD07650-02-9

              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.